Literature DB >> 25486907

Primary venous thromboembolism prophylaxis in patients with solid tumors.

A Casanegra1, A Mansfield, A Tafur.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25486907     DOI： 10.1007/s11239-014-1152-8

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN： 0929-5305            Impact factor:   2.300


× No keyword cloud information.
  8 in total

1.  Catheter-associated deep vein thrombosis of the upper extremity in cancer patients: guidance from the SSC of the ISTH.

Authors:  J I Zwicker; G Connolly; M Carrier; P W Kamphuisen; A Y Y Lee
Journal:  J Thromb Haemost       Date:  2014-05       Impact factor: 5.824

Review 2.  Primary venous thromboembolism prophylaxis in patients with solid tumors: a meta-analysis.

Authors:  Minh Phan; Sonia John; Ana I Casanegra; Suman Rathbun; Aaron Mansfield; Julie A Stoner; Alfonso J Tafur
Journal:  J Thromb Thrombolysis       Date:  2014       Impact factor: 2.300

3.  Odds ratios should be avoided when events are common.

Authors:  D G Altman; J J Deeks; D L Sackett
Journal:  BMJ       Date:  1998-11-07

4.  Prevention of venous thromboembolism in cancer outpatients: guidance from the SSC of the ISTH.

Authors:  A A Khorana; H-M Otten; J I Zwicker; G C Connolly; D F Bancel; I Pabinger
Journal:  J Thromb Haemost       Date:  2014-09-30       Impact factor: 5.824

5.  Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancer.

Authors:  A Maraveyas; J Waters; R Roy; D Fyfe; D Propper; F Lofts; J Sgouros; E Gardiner; K Wedgwood; C Ettelaie; G Bozas
Journal:  Eur J Cancer       Date:  2011-11-17       Impact factor: 9.162

6.  Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trial.

Authors:  Annie M Young; Lucinda J Billingham; Gulnaz Begum; David J Kerr; Ana I Hughes; Daniel W Rea; Stephen Shepherd; Andrew Stanley; Ann Sweeney; Jonathan Wilde; Keith Wheatley
Journal:  Lancet       Date:  2009-02-14       Impact factor: 79.321

7.  Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study.

Authors:  Giancarlo Agnelli; Gualberto Gussoni; Carlo Bianchini; Melina Verso; Mario Mandalà; Luigi Cavanna; Sandro Barni; Roberto Labianca; Franco Buzzi; Giovanni Scambia; Rodolfo Passalacqua; Sergio Ricci; Giampietro Gasparini; Vito Lorusso; Erminio Bonizzoni; Maurizio Tonato
Journal:  Lancet Oncol       Date:  2009-08-31       Impact factor: 41.316

Review 8.  Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.

Authors:  Marcello Di Nisio; Ettore Porreca; Hans-Martin Otten; Anne W S Rutjes
Journal:  Cochrane Database Syst Rev       Date:  2014-08-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.